Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Long-acting beta2-agonists: comparative pharmacology and clinical outcomes.

van der Woude HJ, Aalbers R.

Am J Respir Med. 2002;1(1):55-74. Review.

PMID:
14720076
2.

Long- and short-acting beta2 adrenoceptor agonists: interactions in human contracted bronchi.

Molimard M, Naline E, Zhang Y, Le Gros V, Begaud B, Advenier C.

Eur Respir J. 1998 Mar;11(3):583-8.

3.

Corticosteroids and adrenoceptor agonists: the compliments for combination therapy in chronic airways diseases.

Sin DD, Man SF.

Eur J Pharmacol. 2006 Mar 8;533(1-3):28-35. Epub 2006 Feb 7. Review.

PMID:
16457807
4.

Long-acting inhaled beta2-agonists in asthma therapy.

Moore RH, Khan A, Dickey BF.

Chest. 1998 Apr;113(4):1095-108. Review.

PMID:
9554653
5.
6.

[Long-acting beta-2-agonists in the treatment of asthma].

Rochat T.

Schweiz Med Wochenschr. 1994 Oct 1;124(39):1714-9. German.

PMID:
7939538
7.

Long-acting beta 2-agonists. Role in primary care asthma treatment.

D'Urzo AD.

Can Fam Physician. 1997 Oct;43:1773-7. Review.

8.

Long-acting beta 2-adrenoceptor agonists: a new perspective in the treatment of asthma.

Löfdahl CG, Chung KF.

Eur Respir J. 1991 Feb;4(2):218-26. Review.

PMID:
1675178
10.

Antagonism of long-acting beta2-adrenoceptor agonism.

Lipworth BJ.

Br J Clin Pharmacol. 2002 Sep;54(3):231-45. Review.

11.

Desensitisation of mast cell beta2-adrenoceptor-mediated responses by salmeterol and formoterol.

Scola AM, Chong LK, Suvarna SK, Chess-Williams R, Peachell PT.

Br J Pharmacol. 2004 Jan;141(1):163-71. Epub 2003 Dec 8.

12.

From adrenaline to formoterol: advances in beta-agonist therapy in the treatment of asthma.

Campbell LM.

Int J Clin Pract. 2002 Dec;56(10):783-90. Review.

PMID:
12510953
14.

Pharmacological similarities and differences between beta2-agonists.

Lötvall J.

Respir Med. 2001 Aug;95 Suppl B:S7-11. Review.

15.

Effects of formoterol and salmeterol on the production of Th1- and Th2-related chemokines by monocytes and bronchial epithelial cells.

Hung CH, Chu YT, Hua YM, Hsu SH, Lin CS, Chang HC, Lee MS, Jong YJ.

Eur Respir J. 2008 Jun;31(6):1313-21. doi: 10.1183/09031936.00121406. Epub 2008 Feb 6.

16.

Comparison of the effects of two long-acting beta2-agonists on cytokine secretion by human airway epithelial cells.

Chiu JC, Hsu JY, Fu LS, Chu JJ, Chi CS.

J Microbiol Immunol Infect. 2007 Oct;40(5):388-94.

PMID:
17932597
17.
18.
19.

[Long-acting beta-2-adrenergic agonists in bronchospasm therapy].

Płusa T.

Pol Merkur Lekarski. 1999 May;6(35):227-31. Review. Polish.

PMID:
10437387
20.

Anti-proliferative and anti-remodelling effect of beclomethasone dipropionate, formoterol and salbutamol alone or in combination in primary human bronchial fibroblasts.

Descalzi D, Folli C, Nicolini G, Riccio AM, Gamalero C, Scordamaglia F, Canonica GW.

Allergy. 2008 Apr;63(4):432-7. Epub 2007 Dec 8.

PMID:
18076728

Supplemental Content

Support Center